Literature DB >> 27366166

Antineutrophil Cytoplasmic Antibody Induction due to Infection: A Patient with Infective Endocarditis and Chronic Hepatitis C.

Fareed B Kamar1, T Lee-Ann Hawkins2.   

Abstract

While antineutrophil cytoplasmic antibody (ANCA) is often used as a diagnostic marker for certain vasculitides, ANCA induction in the setting of infection is much less common. In the case of infective endocarditis, patients may present with multisystem disturbances resembling an autoimmune process, cases that may be rendered even trickier to diagnose in the face of a positive ANCA. Though not always straightforward, distinguishing an infective from an inflammatory process is pivotal in order to guide appropriate therapy. We describe an encounter with a 43-year-old male with chronically untreated hepatitis C virus infection who featured ANCA positivity while hospitalized with acute bacterial endocarditis. His case serves as a reminder of two of the few infections known to uncommonly generate ANCA positivity. We also summarize previously reported cases of ANCA positivity in the context of endocarditis and hepatitis C infections.

Entities:  

Year:  2016        PMID: 27366166      PMCID: PMC4904576          DOI: 10.1155/2016/3585860

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


1. Introduction

The antineutrophil cytoplasmic antibody (ANCA) class of immunoglobulins features the principal subtypes c-ANCA and p-ANCA, which are predominantly generated against the cytosolic antigens proteinase 3 (PR3) and myeloperoxidase (MPO), respectively [1]. The presence of these autoantibodies has been described in a variety of autoimmune conditions, such as small-vessel vasculitides, ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis [2, 3]. Less frequently, ANCA induction can occur due to infections such as amebiasis, endocarditis, tuberculosis, malaria, human immunodeficiency virus infection, and hepatitis C virus (HCV) infection [2, 4]. Because autoimmune and infectious diseases may present similarly, ANCA positivity must be carefully interpreted [5]. The following case describes a 43-year-old male with chronically untreated HCV infection who was admitted to hospital with infective endocarditis and was found to be c-ANCA positive. We also summarize the literature concerning ANCA positivity in endocarditis and HCV infections.

2. Clinical Vignette

A 43-year-old male with a history of HCV infection (untreated since his diagnosis six years previously, with an RNA viral load of 1584 IU/mL on admission) and intravenous polysubstance use presented to a medical center with acute fever, dyspnea, and arthralgia. He was found to have purpura over his edematous lower extremities. His initial laboratory investigations featured an elevated white blood cell count of 16 × 109 cells per liter, elevated C-reactive protein of 183 mg/L, urinalysis that was positive for hematuria, and blood cultures that were later positive for methicillin-sensitive Staphylococcus aureus. He did feature transient acute kidney injury soon after admission (peak serum creatinine 283 umol/L). His serology was also positive for c-ANCA (anti-PR3), antinuclear antibody, and weakly positive for type III cryoglobulinemia. An echocardiogram revealed 1.1 × 1.3 cm tricuspid vegetation involving the anterior and septal leaflets. A computerized tomography scan of his chest illustrated multiple bilateral septic pulmonary emboli, bilateral pleural effusions, and an anterior mediastinal abscess. A punch biopsy of a purpuric lesion on his right shin, performed one week into antibiotic therapy as his purpura was resolving (Figure 1(a)), revealed mild perivascular inflammation with focally extravasated erythrocytes and hemosiderin deposits consistent with a mild or resolving purpuric process (Figure 1(b)). The patient demonstrated clinical improvement during a six-week course of cefazolin.
Figure 1

(a) Photograph of the patient's resolving purpura involving his legs one week into antibiotic therapy. (b) Corresponding hematoxylin and eosin-stained histopathology at 20x magnification of a punch biopsy of one of the lesions on his leg, showing mild perivascular inflammation with focally extravasated erythrocytes consistent with a resolving purpuric process. No leukocytoclastic vasculitis was seen.

3. Discussion

ANCA positivity may pose a diagnostic and therapeutic quandary in the face of patient presentation consistent with either a vasculitic or infectious process, particularly in the case of infective endocarditis [6]. A literature search of previously published cases concerning ANCA induction in infective endocarditis was performed via PubMed and Medline using the title and abstract entries “endocarditis” and “ANCA or antineutrophil cytoplasmic antibody,” yielding 70 relevant cases [1, 5–39]. A recent publication by Ying et al. (2014) describes 13 of these cases in addition to a literature review of several other ones [7]. We have expanded on this review through the addition of 26 other cases (Table 1).
Table 1

Number of positive clinical and laboratory characteristics among all previously reported cases of ANCA-positive infective endocarditis.

Patient characteristicProportion among 70 reported patient cases
Mean age (years)53.2
Male/female54/16
Valve involvement56/70
 Aortic22
 Mitral16
 Left-sided not otherwise specified7
 Aortic plus mitral6
 Tricuspid5
 Pulmonary1
 Mitral plus pulmonary and tricuspid1
 Ventricular septal defect1
Clinical features
 Fever46
 Anemia34
 Splenomegaly19
 Nephropathy (GN or AKI)43
 Arthralgia17
 Lower extremity edema23
 Rash15
 Purpura11
 Cerebral infarction7
 Finger clubbing4
Laboratory results
 PR352
 MPO8
 PR3 + MPO7
 Hematuria49
 Proteinuria14
Microbiology
 Positive blood culture54/70
 Pathogen
   Streptococcus spp.28
   Enterococcus spp.7
   Staphylococcus spp.10
   Bartonella spp.9
   Neisseria spp.1
   Propionibacterium spp.1
   Haemophilus spp.1
   Gemella spp.1
   Aggregatibacter spp.1

GN: glomerulonephritis; AKI: acute kidney injury; PR3: proteinase 3; MPO: myeloperoxidase; spp.: species.

This table, taken from Ying et al. (2014) with permission, expands the review from the original 44 patients to include 26 others [7].

A set of diagnostic aids between infective endocarditis and small-vessel vasculitis has been previously outlined (Table 2) [8]. One similarity, for example, is acute renal failure, the prevalence of which in bacterial endocarditis is 30% and is a significant predictor of mortality [40]. Glomerulonephritis in infective endocarditis is either pauci-immune, postinfective, or subendothelial membranoproliferative [41], the etiology of which can usually be discerned by obtaining a kidney biopsy [8].
Table 2

Diagnostic aids for differentiating between infectious endocarditis and small-vessel vasculitis.

Similaritiesa Differencesb
(i) Presentation with constitutional symptoms(i) Splenomegaly
(ii) Pyrexia(ii) Thrombocytopenia
(iii) Active urinary sediment(iii) Hypocomplementemia
(iv) Skin involvement(iv) Immune complexes
(v) Decreased GFR(v) Other positive autoantibodies
(vi) Increased inflammatory marker levels(vi) Low titer ANCA/ELISA negative
(vii) Other organ involvement

ANCA: antineutrophil cytoplasmic antibody; ELISA: enzyme-linked immunosorbent assay; GFR: glomerular filtration rate.

aFeatures seen in both conditions.

bFeatures seen predominantly in infectious endocarditis.

This table was taken from Forbes et al. (2012) with permission [8].

Another ANCA-associated infection present in our reported patient is HCV infection. Previously published cases of ANCA induction due to hepatitis C infection are also summarized (Table 3) [6, 9, 42–54]. Our case report hence features two possible infections for c-ANCA induction, both of which likely also contributed to the patient's cryoglobulinemia. Because ANCA induction is more common in chronic infections [6], it argues for hepatitis C as the cause of this patient's ANCA positivity as opposed to the more acute infection Staphylococcus aureus endocarditis [55]. Had his ANCA status been checked after endocarditis recovery, ANCA induction due to endocarditis as opposed to hepatitis C would have also been supported by a normalized or negative ANCA titer [11].
Table 3

Summary of previously published ANCA-positive hepatitis C infection cases.

PaperAge (years), sexANCA Miscellaneous features
Bonaci-Nikolic et al., 2010 [6]63, FMPO
51, FMPO
24, FMPO

Cojocaru et al., 2007 [42] Mean 7521 PR3Concomitant ischemic stroke

Cojocaru et al., 2006 [43] ??

Gatselis et al., 2006 [44] ?65 c-ANCA, 4 p-ANCA (though all negative for PR3 and MPO)

Lamprecht et al., 2003 [9] ?6 bactericidal/permeability-increasing proteinsMixed cryoglobulinemia
4 cathepsin G proteins
1 unknown antigen (c-ANCA)
2 bactericidal/permeability-increasing proteinsNo cryoglobulinemia
Four patients: cathepsin G

Zandman-Goddard et al., 2003 [45]34, Mc-ANCA and p-ANCAComplicated by transverse myelitis

Tajima et al., 2002 [46]66, Fp-ANCAComplicated by pachymeningitis

Wu et al., 2002 [47]?253 PR3,25 PR3 and MPOHigher proportion of ANCA-positive compared to ANCA-negative patients with high alanine aminotransferase, high alpha-fetoprotein, skin disease, cirrhosis, and anemia

Agarwal et al., 2001 [48]?5 p-ANCA

Igaki et al., 2000 [49]60, FMPOGlomerulonephritis, cryoglobulinemia

Lamprecht et al., 1998 [50]60, Fc-ANCAType II cryoglobulinemia

Ohira et al., 1998 [51]?12 c-ANCA or p-ANCA

Kallinowski et al., 1997 [52]?5 ANCA

Papi et al., 1997 [53]63, FMPOMixed type II cryoglobulinemia, leukocytoclastic vasculitis on skin biopsy

Dalekos and Tsianos, 1994 [54]?3 ANCA

F: female; ANCA: antineutrophil cytoplasmic antibody; MPO: myeloperoxidase; PR3: proteinase 3.

4. Conclusion

In light of its use in the diagnostic evaluation of vasculitis, a positive ANCA may allow for an infection to mislead a diagnostician down the path of autoimmune possibilities, particularly in the context of infective endocarditis. While clues may be drawn from clinical, laboratory, and radiological data to help differentiate infective endocarditis from vasculitis, obtaining blood cultures is of foremost importance. Making such a distinction will avoid the detrimental consequence of initiating immunosuppressive therapy against an infection masquerading as an inflammatory disease.
  54 in total

Review 1.  Clinical utility of testing for antineutrophil cytoplasmic antibodies.

Authors:  D Vassilopoulos; G S Hoffman
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  [Rapidly progressive ANCA positive glomerulonephritis as the presenting feature of infectious endocarditis].

Authors:  W Hanf; J-E Serre; J-H Salmon; N Fabien; I Ginon; F Dijoud; P Trolliet
Journal:  Rev Med Interne       Date:  2011-01-31       Impact factor: 0.728

3.  Is vasculitis in subacute bacterial endocarditis associated with ANCA?

Authors:  J Wagner; K Andrassy; E Ritz
Journal:  Lancet       Date:  1991-03-30       Impact factor: 79.321

4.  Significance of hepatitis B, hepatitis C and GBV-C in ANCA-positive hemodialysis patients.

Authors:  B Kallinowski; S Seipp; S Fatehi; U Sommerfeld; K Andrassy; W Stremmel; L Theilmann
Journal:  Nephron       Date:  1997       Impact factor: 2.847

5.  Mixed cryoglobulinaemia, glomerulonephritis, and ANCA: essential cryoglobulinaemic vasculitis or ANCA-associated vasculitis?

Authors:  P Lamprecht; W H Schmitt; W L Gross
Journal:  Nephrol Dial Transplant       Date:  1998-01       Impact factor: 5.992

6.  Three cases of PR3-ANCA positive subacute endocarditis caused by attenuated bacteria (Propionibacterium, Gemella, and Bartonella) complicated with kidney injury.

Authors:  Kenji Satake; Isao Ohsawa; Noriyoshi Kobayashi; Ken Osaki; Hitoe Toyoda; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Mod Rheumatol       Date:  2011-03-15       Impact factor: 3.023

Review 7.  Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.

Authors:  Elena Csernok; Peter Lamprecht; Wolfgang L Gross
Journal:  Curr Opin Rheumatol       Date:  2010-01       Impact factor: 5.006

8.  Vasculitic purpura with antineutrophil cytoplasmic antibody-positive acute renal failure in a patient with Streptococcus bovis case and Neisseria subflava bacteremia and subacute endocarditis.

Authors:  A Bauer; W J Jabs; S Süfke; M Maass; B Kreft
Journal:  Clin Nephrol       Date:  2004-08       Impact factor: 0.975

9.  Ischemic stroke accompanied by anti-PR3 antibody-related cerebral vasculitis and hepatitis C virus infection.

Authors:  Inimioara Mihaela Cojocaru; M Cojocaru; Cecilia Burcin
Journal:  Rom J Intern Med       Date:  2007

10.  Touch not the cat bot a glove*: ANCA-positive pauci-immune necrotizing glomerulonephritis secondary to Bartonella henselae.

Authors:  Shahzad H Shah; Cairistine Grahame-Clarke; Calum N Ross
Journal:  Clin Kidney J       Date:  2014-01-12
View more
  3 in total

1.  Case Report: Patient with Hepatitis C, p-ANCA, and Cryoglobulin Antibodies Presenting with Necrotizing Crescentic p-ANCA Glomerulonephritis.

Authors:  Ramy M Hanna; Naomi So; Marian Kaldas; Jean Hou; Farid Arman; Michelle Sangalang; Bishoy Yanny; Umut Selamet; Sammy Saab; Niloofar Nobakht; Anjay Rastogi
Journal:  Case Rep Nephrol Dial       Date:  2018-08-10

Review 2.  Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature.

Authors:  Inge C Van Gool; Jesper Kers; Jaap A Bakker; Joris I Rotmans; Y K Onno Teng; Martijn P Bauer
Journal:  Clin Rheumatol       Date:  2022-06-23       Impact factor: 3.650

3.  Severe Infection in Anti-Glomerular Basement Membrane Disease: A Retrospective Multicenter French Study.

Authors:  Pauline Caillard; Cécile Vigneau; Jean-Michel Halimi; Marc Hazzan; Eric Thervet; Morgane Heitz; Laurent Juillard; Vincent Audard; Marion Rabant; Alexandre Hertig; Jean-François Subra; Vincent Vuiblet; Dominique Guerrot; Mathilde Tamain; Marie Essig; Thierry Lobbedez; Thomas Quemeneur; Jean-Michel Rebibou; Alexandre Ganea; Marie-Noëlle Peraldi; François Vrtovsnik; Maïté Daroux; Adnane Lamrani; Raïfah Makdassi; Gabriel Choukroun; Dimitri Titeca-Beauport
Journal:  J Clin Med       Date:  2020-03-04       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.